AMILI, a precision gut microbiome firm, raises new funding led by East Ventures
AMILI, Southeast Asia’s first and only precision gut microbiome company, today announced that it has secured new funding from East Ventures, a pioneering sector-agnostic venture capital firm that has supported over 300 tech companies across Southeast Asia. This fund strengthens AMILI’s balance sheet, following the company’s series A funding in June 2022.
One medical health record helps with decision-making: Sharlini Eriza Putri, Co-founder & CEO of Nusantics
Startups are indeed the backbone of the digital economy. Startups play an important role in shaping and developing digital economic ecosystems. While conventional businesses only adapt digitalization for internal systems, transaction needs, and other things. The important thing about the digital economy is that it can provide value to people who previously did not have access.
Vietnam-based telehealth platform Medigo bags US$ 2 million in series A funding led by East Ventures
Medigo, a Vietnam-based telehealth platform that provides on-demand medicine prescription and delivery services, has successfully raised US$ 2 million in a series A funding round led by East Ventures, with the participation from Pavilion Capital and Touchstone Partners. With the added capital, Medigo plans to strengthen its services and develop a healthcare ecosystem in Vietnam.
How private and public sectors can collaborate to advance the Indonesian healthcare system
East Ventures has recently launched the White paper: “Genomics: Leapfrogging into the Indonesian healthcare future”, a collaborative report with Indonesia’s Health Ministry and a global consulting company, Redseer, on 16 February 2022, in Jakarta, Indonesia.
East Ventures launched a white paper on genomics in collaboration with the Ministry of Health of the Republic of Indonesia
East Ventures today launched a white paper “Genomics: Leapfrogging into the Indonesian healthcare future” in collaboration with the Ministry of Health of the Republic of Indonesia and Redseer Strategy Consultants, to provide a comprehensive understanding of how genomics can improve the healthcare system in Indonesia. This white paper serves as a guide for stakeholders in taking the necessary steps to improve our healthcare system and infrastructure for the future.
Why Indonesia should embrace genomics now
Two of the most critical pain points of Indonesia's healthcare system is the high mortality rates for non-communicable diseases, and high cost of treatment. The solution to this is developing genomics. Genomics technology will allow for early detection and targeted treatment, paving the way ahead to transform our healthcare system.
A healthy lifestyle begins at your fingertips
A study from the AIA Group in 2018 showed that Indonesia ranked the lowest in the Asia Pacific regarding the application of a healthy lifestyle. Despite being satisfied with their health condition, the research also revealed that Indonesians’ healthy living activities decreased from 4.0 in 2016 to 3.6 in 2018.
Indonesia’s Health & Biotechnology Investment Opportunities
During the East Ventures Summit 2022, Budi Gunadi Sadikin, Indonesian Minister of Health, was invited to become our keynote speaker, who presented his few insights on Indonesia's Health & Biotechnology Investment Opportunities.